Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device.
Jablonska PA, Parent A, La Macchia N, Chan HHL, Filleti M, Ramotar M, Cho YB, Braganza M, Badzynski A, Laperriere N, Conrad T, Tsang DS, Shultz D, Santiago A, Irish JC, Millar BA, Tadic T, Berlin A. Jablonska PA, et al. Among authors: ramotar m. Clin Transl Radiat Oncol. 2023 Jul 26;42:100663. doi: 10.1016/j.ctro.2023.100663. eCollection 2023 Sep. Clin Transl Radiat Oncol. 2023. PMID: 37587925 Free PMC article.
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases.
Ramotar M, Barnes S, Moraes F, Dasgupta A, Laperriere N, Millar BA, Berlin A, Conrad T, van Prooijen M, Damyanovich A, Heaton R, Cho YB, Coolens C, Liu G, Shepherd FA, Bradbury P, Leighl N, Bernstein M, Zadeh G, Kongkham P, Doherty M, Shultz DB. Ramotar M, et al. Adv Radiat Oncol. 2019 Nov 26;5(3):350-357. doi: 10.1016/j.adro.2019.11.002. eCollection 2020 May-Jun. Adv Radiat Oncol. 2019. PMID: 32529128 Free PMC article.
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer.
Moraes FY, Mansouri A, Dasgupta A, Ramotar M, Kosyak N, Weiss J, Laperriere N, Millar BA, Berlin A, Conrad T, van Prooijen M, Heaton R, Coolens C, Winter J, Bernstein M, Zadeh G, Kongkham P, Doherty M, Shultz DB. Moraes FY, et al. Among authors: ramotar m. Lung Cancer. 2021 May;155:34-39. doi: 10.1016/j.lungcan.2021.02.036. Epub 2021 Mar 2. Lung Cancer. 2021. PMID: 33721614
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Glicksman RM, Ramotar M, Metser U, Chung PW, Liu Z, Vines D, Finelli A, Hamilton R, Fleshner NE, Perlis N, Zlotta AR, Bayley A, Helou J, Raman S, Kulkarni G, Catton C, Lam T, Chan R, Warde P, Gospodarowicz M, Jaffray DA, Berlin A. Glicksman RM, et al. Among authors: ramotar m. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):693-704. doi: 10.1016/j.ijrobp.2022.06.080. Epub 2022 Aug 27. Int J Radiat Oncol Biol Phys. 2022. PMID: 36031465 Clinical Trial.
Physician Perception of Grade Group 1 Prostate Cancer.
Saoud R, Woranisarakul V, Paner GP, Ramotar M, Berlin A, Cooperberg M, Eggener SE. Saoud R, et al. Among authors: ramotar m. Eur Urol Focus. 2023 Nov;9(6):966-973. doi: 10.1016/j.euf.2023.04.002. Epub 2023 Apr 26. Eur Urol Focus. 2023. PMID: 37117112
[No title available]
[No authors listed] [No authors listed] PMID: 37784586
[No title available]
[No authors listed] [No authors listed] PMID: 37785306
18 results